LU
Lunai Bioworks Inc.
RENB | US
Overview
Corporate Details
- ISIN(s):
- US29350E1047
- LEI:
- Country:
- United States of America
- Address:
- CENTURY CITY MEDICAL PLAZA, 90067 SUITE 906 LOS ANGELES
- Website:
- https://www.lunaibio.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lunai Bioworks Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Lunai Bioworks Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lunai Bioworks Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
United States of America
RFL
Develops ionization tech to generate rain and mitigate fog for water-scarce regions.
United States of America
RAIN
United States of America
RAIN
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America
RLYB
United States of America
RLYB
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Japan
4579
AI-driven biotech accelerating drug discovery for rare diseases and oncology.
United States of America
RXRX
United States of America
RXRX
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
United States of America
RLMD
Develops a device platform for delivering targeted therapies directly to solid tumors.
United States of America
RNXT
United States of America
RNXT
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America
RPTX
United States of America
RPTX
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
United States of America
REPL
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
Japan
4978